FGAM
UTHR icon

Financial Gravity Asset Management’s United Therapeutics UTHR Stock Holding History

Financial Gravity Asset Management’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-1
Closed -$290 – 1777
2024
Q1 		$290 Buy
+1
New +$226 ﹤0.01% 913
2023
Q4 		– Hold
0
– – – 997
2021
Q3 		$185K Sell
2
-16
-89% -$3.15K 0.09% 202
2021
Q2 		$179K Buy
+18
New +$3.43K 0.06% 209
2020
Q4 		$3K Buy
+20
New +$2.63K ﹤0.01% 290
2019
Q2 		– Sell
-390
Closed -$46K – 1681
2019
Q1 		$46K Buy
+390
New +$45.4K 0.04% 333

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Financial Gravity Asset Management's UTHR Position: Q2 2024 in Review

Financial Gravity Asset Management sold out of United Therapeutics (UTHR) in Q2 2024, closing a stake of 1 share — an estimated $290 sold.

Financial Gravity Asset Management first reported a position in UTHR in Q1 2019 and held it in 5 quarters. The position peaked at $185K in Q3 2021. 568 funds tracked by Wall St. Rank hold UTHR as of Q2 2024.

  • Financial Gravity Asset Management reported no remaining United Therapeutics position as of Q2 2024 after selling out during the quarter.
  • Financial Gravity Asset Management sold 1 United Therapeutics share in Q2 2024, an estimated $290.
  • Financial Gravity Asset Management first reported a position in United Therapeutics in Q1 2019 and held it in 5 quarters.
  • Financial Gravity Asset Management's United Therapeutics position peaked at $185K in Q3 2021.
  • 568 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2024.

Based on Financial Gravity Asset Management's 13F filing for Q2 2024, filed 6 Aug 2024.